Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zebrafish | 12 | 2023 | 118 | 3.800 |
Why?
|
| Ethanol | 8 | 2023 | 188 | 3.120 |
Why?
|
| Zebrafish Proteins | 4 | 2020 | 45 | 2.030 |
Why?
|
| Embryo, Nonmammalian | 6 | 2022 | 57 | 1.790 |
Why?
|
| Hedgehog Proteins | 5 | 2023 | 45 | 1.640 |
Why?
|
| Cannabinoids | 2 | 2023 | 54 | 1.530 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2019 | 283 | 1.500 |
Why?
|
| Agrin | 4 | 2023 | 5 | 0.920 |
Why?
|
| Neurosciences | 1 | 2022 | 23 | 0.850 |
Why?
|
| Neurogenesis | 2 | 2020 | 55 | 0.830 |
Why?
|
| Fibroblast Growth Factors | 1 | 2020 | 34 | 0.750 |
Why?
|
| Central Nervous System Depressants | 1 | 2020 | 37 | 0.750 |
Why?
|
| Minority Groups | 1 | 2022 | 537 | 0.610 |
Why?
|
| Tretinoin | 1 | 2015 | 50 | 0.530 |
Why?
|
| Eye | 2 | 2015 | 68 | 0.510 |
Why?
|
| Animals | 17 | 2023 | 14307 | 0.490 |
Why?
|
| Animals, Genetically Modified | 4 | 2011 | 93 | 0.480 |
Why?
|
| Neurodegenerative Diseases | 3 | 2009 | 119 | 0.430 |
Why?
|
| Homeodomain Proteins | 4 | 2015 | 128 | 0.420 |
Why?
|
| Nervous System | 1 | 2012 | 29 | 0.420 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2007 | 95 | 0.360 |
Why?
|
| Paired Box Transcription Factors | 3 | 2015 | 7 | 0.340 |
Why?
|
| Eye Proteins | 3 | 2015 | 46 | 0.330 |
Why?
|
| Glutamate Decarboxylase | 2 | 2020 | 17 | 0.320 |
Why?
|
| Body Patterning | 1 | 2007 | 23 | 0.320 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2007 | 36 | 0.310 |
Why?
|
| Alzheimer Disease | 4 | 2007 | 881 | 0.300 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2007 | 68 | 0.300 |
Why?
|
| Glycoproteins | 1 | 2007 | 100 | 0.300 |
Why?
|
| Central Nervous System | 1 | 2007 | 130 | 0.290 |
Why?
|
| Repressor Proteins | 3 | 2015 | 226 | 0.290 |
Why?
|
| alpha-Synuclein | 1 | 2005 | 48 | 0.260 |
Why?
|
| Neuroprotective Agents | 1 | 2007 | 231 | 0.260 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 1300 | 0.240 |
Why?
|
| Edema, Cardiac | 1 | 2023 | 1 | 0.240 |
Why?
|
| In Situ Hybridization | 2 | 2020 | 125 | 0.220 |
Why?
|
| Brain | 4 | 2015 | 1268 | 0.210 |
Why?
|
| Models, Animal | 3 | 2013 | 131 | 0.210 |
Why?
|
| Hospitals | 1 | 2022 | 86 | 0.210 |
Why?
|
| Heart | 1 | 2023 | 178 | 0.200 |
Why?
|
| Pregnancy | 3 | 2022 | 1503 | 0.200 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2022 | 155 | 0.190 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2020 | 40 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 3 | 2013 | 484 | 0.160 |
Why?
|
| Behavior, Animal | 1 | 2020 | 304 | 0.160 |
Why?
|
| Green Fluorescent Proteins | 2 | 2009 | 200 | 0.160 |
Why?
|
| Gene Expression | 1 | 2020 | 639 | 0.150 |
Why?
|
| Basement Membrane | 2 | 2010 | 28 | 0.150 |
Why?
|
| Risk-Taking | 1 | 2020 | 435 | 0.150 |
Why?
|
| Parkinson Disease | 2 | 2007 | 167 | 0.130 |
Why?
|
| Retina | 2 | 2010 | 255 | 0.120 |
Why?
|
| Keratin-5 | 2 | 2013 | 8 | 0.120 |
Why?
|
| Barrett Esophagus | 1 | 2013 | 29 | 0.110 |
Why?
|
| Esophagus | 1 | 2013 | 41 | 0.110 |
Why?
|
| Collagen Type IV | 2 | 2010 | 48 | 0.110 |
Why?
|
| Laminin | 2 | 2010 | 59 | 0.110 |
Why?
|
| Motor Neurons | 1 | 2012 | 72 | 0.100 |
Why?
|
| Microphthalmos | 1 | 2011 | 1 | 0.100 |
Why?
|
| Oligoribonucleotides, Antisense | 1 | 2011 | 3 | 0.100 |
Why?
|
| Neural Pathways | 1 | 2012 | 120 | 0.100 |
Why?
|
| Female | 5 | 2022 | 19873 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2007 | 1152 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2013 | 781 | 0.090 |
Why?
|
| Tongue | 1 | 2009 | 11 | 0.090 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2009 | 35 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2010 | 143 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2009 | 59 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2015 | 1802 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2011 | 420 | 0.090 |
Why?
|
| Environmental Exposure | 1 | 2011 | 207 | 0.080 |
Why?
|
| Phenotype | 1 | 2011 | 650 | 0.080 |
Why?
|
| Docosahexaenoic Acids | 1 | 2007 | 18 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 859 | 0.080 |
Why?
|
| Breeding | 1 | 2007 | 21 | 0.080 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2007 | 60 | 0.070 |
Why?
|
| Tissue Distribution | 1 | 2007 | 197 | 0.070 |
Why?
|
| Plasmids | 1 | 2007 | 233 | 0.070 |
Why?
|
| Synucleins | 1 | 2005 | 6 | 0.070 |
Why?
|
| Prions | 1 | 2005 | 25 | 0.070 |
Why?
|
| Lewy Bodies | 1 | 2005 | 28 | 0.070 |
Why?
|
| Circular Dichroism | 1 | 2005 | 60 | 0.070 |
Why?
|
| Heparitin Sulfate | 1 | 2005 | 23 | 0.070 |
Why?
|
| Substantia Nigra | 1 | 2005 | 41 | 0.070 |
Why?
|
| Solubility | 1 | 2005 | 115 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2005 | 170 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 195 | 0.070 |
Why?
|
| Aging | 1 | 2009 | 639 | 0.060 |
Why?
|
| Chickens | 1 | 2005 | 123 | 0.060 |
Why?
|
| Models, Biological | 1 | 2007 | 642 | 0.060 |
Why?
|
| Cell Death | 1 | 2005 | 260 | 0.060 |
Why?
|
| Protein Conformation | 1 | 2005 | 350 | 0.060 |
Why?
|
| Humans | 6 | 2022 | 34853 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 485 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 445 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 282 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 600 | 0.060 |
Why?
|
| Chick Embryo | 1 | 2002 | 71 | 0.050 |
Why?
|
| Protein Binding | 1 | 2005 | 913 | 0.050 |
Why?
|
| Mutation | 1 | 2006 | 1023 | 0.050 |
Why?
|
| Time Factors | 1 | 2005 | 1681 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 338 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2002 | 562 | 0.040 |
Why?
|
| Neurons | 1 | 2005 | 1130 | 0.040 |
Why?
|
| Mice | 1 | 2006 | 5668 | 0.030 |
Why?
|
| Metaplasia | 1 | 2013 | 34 | 0.030 |
Why?
|
| Mucins | 1 | 2013 | 33 | 0.030 |
Why?
|
| Epithelium | 1 | 2013 | 74 | 0.030 |
Why?
|
| Larva | 1 | 2013 | 117 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 298 | 0.030 |
Why?
|
| Male | 2 | 2010 | 18870 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 430 | 0.030 |
Why?
|
| Keratin-15 | 1 | 2009 | 2 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 59 | 0.020 |
Why?
|
| Fetus | 1 | 2010 | 103 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2009 | 29 | 0.020 |
Why?
|
| Flavonoids | 1 | 2009 | 78 | 0.020 |
Why?
|
| Phenols | 1 | 2009 | 76 | 0.020 |
Why?
|
| Fruit | 1 | 2009 | 159 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2009 | 196 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 834 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 1149 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1007 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 1490 | 0.020 |
Why?
|
| Antioxidants | 1 | 2009 | 386 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2009 | 371 | 0.020 |
Why?
|
| Collagen Type XVIII | 1 | 2002 | 1 | 0.010 |
Why?
|
| Endostatins | 1 | 2002 | 5 | 0.010 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2002 | 12 | 0.010 |
Why?
|
| Ciliary Body | 1 | 2002 | 23 | 0.010 |
Why?
|
| Collagen | 1 | 2002 | 162 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 197 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2002 | 298 | 0.010 |
Why?
|
| Adult | 1 | 2010 | 11034 | 0.010 |
Why?
|